Global Medical Silicone Radiopaque Vascular Ties Market Size, Share, and COVID-19 Impact Analysis, By Type (Occlusion Ties, Retracting Ties, and Marking Ties), By Application (Cardiovascular & Thoracic Surgery, Neurosurgery, General Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Dec 2025
REPORT ID SI16494
PAGES 245
REPORT FORMAT PathSoft

Global Medical Silicone Radiopaque Vascular Ties Market Insights Forecasts to 2035

  • The Global Medical Silicone Radiopaque Vascular Ties Market Size Was Estimated at USD 40.8 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 3.23% from 2025 to 2035
  • The Worldwide Medical Silicone Radiopaque Vascular Ties Market Size is Expected to Reach USD 57.9 Million by 2035
  • Asia Pacific is expected to grow the fastest during the forecast period.

 According to a research report published by Spherical Insights and Consulting, the global medical silicone radiopaque vascular ties market size was worth around USD 40.8 million in 2024 and is predicted to grow to around USD 57.9 million by 2035 with a compound annual growth rate (CAGR) of 3.23% from 2025 to 2035. The worldwide market for silicone radiopaque vascular ties is expanding due to the surge in minimally invasive surgeries, the higher incidence of chronic cardiovascular conditions, and the ageing demographic.

Market Overview

The worldwide market for silicone radiopaque vascular ties refers to specialized silicone surgical ties that contain radiopaque substances, making them clearly visible in X-ray or fluoroscopic imaging. These tools are utilized to block, retract or mark blood vessels in cardiovascular, neurovascular and minimally invasive procedures, improving accuracy and safety. This market's growth is driven by an increase in procedures, a rising prevalence of chronic vascular diseases, and continuous improvements in silicone radiopacity and biocompatibility.

Opportunities emerge from the growing adoption of methods, the shift to single-use sterile surgical tools and increased healthcare investment in developing regions. Additionally, advancements in image-guided surgery create avenues for innovation. Leading firms in the industry include manufacturers of silicone components, vascular access instruments, and surgical equipment, such as Freudenberg Medical, Elkem Silicones, and Trelleborg Healthcare & Medical, alongside dedicated OEM/ODM medical device producers supplying radiopaque silicone parts for applications. In June 2025, the World Health Organization hosted its Global Forum on Medical Devices, bringing together regulators, industry leaders and healthcare specialists from than 130 nations. The event centred on enhancing access, safety, cost-effectiveness and technological progress by fostering cooperation to support devices such as radiopaque vascular ties.

Report Coverage

This research report categorizes the medical silicone radiopaque vascular ties market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the medical silicone radiopaque vascular ties market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the medical silicone radiopaque vascular ties market.

Driving Factors

The worldwide market for silicone radiopaque vascular ties is propelled by the increase in surgical procedures, especially in cardiovascular, neurovascular and minimally invasive surgeries that need exact vessel identification. The growing incidence of conditions like atherosclerosis and diabetes boosts the need for dependable vessel-management solutions. Innovations in silicone materials enhance imaging clarity and surgical security. The market expansion is also driven by the use of sterile equipment, regulatory emphasis on patient protection and the growth of healthcare facilities in developing regions. In October 2025, China's NMPA implemented the Measures to Optimize Life-Cycle Regulation, enabling quicker authorization and market introduction for advanced biomaterial-based devices, such as radiopaque silicone vascular ties.

Restraining Factors

The medical silicone radiopaque vascular ties market faces restraints, including high production costs, stringent regulatory approvals, and limited reimbursement policies. Technical challenges in maintaining radiopacity and flexibility, combined with competition from alternative vessel-management d

Market Segmentation

The medical silicone radiopaque vascular ties market share is classified into type and application.  

  • The occlusion ties segment dominated the market in 2024, approximately 45% and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the medical silicone radiopaque vascular ties market is divided into occlusion ties, retracting ties, and marking ties. Among these, the occlusion ties segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The expansion of occlusion ties is propelled by their function in regulating blood flow during operations, particularly in cardiovascular and thoracic surgeries. Their radiopaque feature allows for positioning under fluoroscopic guidance. The increasing incidence of diseases combined with progress in minimally invasive surgeries is boosting the need for dependable, efficient vascular ties, solidifying the dominant position of occlusion ties in the marketevices, slow adoption. Additionally, the lack of awareness among healthcare providers in emerging markets limits market expansion.

The market is anticipated to grow at a significant CAGR during the forecast period. Growth is driven by the rising incidence of cardiovascular diseases and an increasing number of thoracic surgeries, which require precise vascular management. Silicone radiopaque ties, particularly occlusion ties, improve blood flow control and enhance surgical accuracy. Additionally, advancements in minimally invasive techniques and surgical technologies are boosting the demand for high-quality vascular ties, ultimately improving procedure safety and patient outcomes.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies